Detalhe da pesquisa
1.
Coagulopathy of Coronavirus Disease 2019.
Crit Care Med
; 48(9): 1358-1364, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467443
2.
The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Inflamm Res
; 69(12): 1181-1189, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918567
3.
The unique characteristics of COVID-19 coagulopathy.
Crit Care
; 24(1): 360, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552865
4.
Deranged Balance of Hemostasis and Fibrinolysis in Disseminated Intravascular Coagulation: Assessment and Relevance in Different Clinical Settings.
Anesthesiology
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861325
5.
Anticoagulation in COVID-19: reaction to the ACTION trial.
Lancet
; 397(10291): 2226-2228, 2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119049
6.
Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population-based analysis in response to CVS 2022 formulary changes.
Am J Hematol
; 97(5): E173-E176, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35147235
7.
The authors reply.
Crit Care Med
; 48(11): e1160-e1161, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32932349
8.
The authors reply.
Crit Care Med
; 48(10): e989-e990, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931200
9.
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.
Blood Rev
; 66: 101218, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38852017
10.
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.
J Thromb Haemost
; 22(6): 1779-1797, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503600
11.
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.
J Intensive Care
; 11(1): 24, 2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221630
12.
How to manage coagulopathies in critically ill patients.
Intensive Care Med
; 49(3): 273-290, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808215
13.
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis.
Cardiovasc Res
; 119(11): 2046-2060, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253117
14.
Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management.
EClinicalMedicine
; 44: 101276, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128366
15.
ISTH guidelines for antithrombotic treatment in COVID-19.
J Thromb Haemost
; 20(10): 2214-2225, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906716
16.
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day.
J Thromb Haemost
; 20(12): 2964-2971, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201366
17.
Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants.
Postgrad Med
; 133(5): 508-516, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480813
18.
Factor XI Deficiency.
Hematol Oncol Clin North Am
; 35(6): 1157-1169, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535287
19.
Recent advances in the research and management of sepsis-associated DIC.
Int J Hematol
; 113(1): 24-33, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386597
20.
Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
Int J Hematol
; 113(3): 330-336, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471294